[Physiologic and physiopathologic implications of insulin-receptor interaction (III)].
D000015:Abnormalities, Multiple / Q000378:metabolism; D000052:Acanthosis Nigricans / Q000378:metabolism; D000172:Acromegaly / Q000378:metabolism; D000856:Anorexia Nervosa / Q000378:metabolism; D001260:Ataxia Telangiectasia / Q000378:metabolism; D003480:Cushing Syndrome / Q000378:metabolism; D003550:Cystic Fibrosis / Q000378:metabolism; D003920:Diabetes Mellitus / Q000378:metabolism; D016883:Diabetic Ketoacidosis / Q000378:metabolism; D006801:Humans; D007018:Hypopituitarism / Q000378:metabolism; D007328:Insulin / Q000378:metabolism*; D007333:Insulin Resistance; D007713:Klinefelter Syndrome / Q000378:metabolism; D008060:Lipodystrophy / Q000378:metabolism; D009223:Myotonic Dystrophy / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism*; D014898:Werner Syndrome / Q000378:metabolism
D007328:Insulin; D011972:Receptor, Insulin
Implicaciones fisiológicas y fisiopatológicas de la interacción insulina-receptor (III).